{"id":"W2969950347","doi":"10.1007/s10549-019-05398-3","title":"Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Georgetown University; GlaxoSmithKline; Breast Cancer Research Foundation","keywords":"Trastuzumab; Lapatinib; Medicine; Oncology; Internal medicine; Breast cancer; Chemotherapy; Estrogen receptor; Proportional hazards model; Neoadjuvant therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002016183,0.0004938083,0.0008300182,0.0002502784,0.0002302212,0.0004646349,0.0002720983,0.0004693446,0.001067376],"category_scores_gemma":[0.001393701,0.0002994704,0.0007814011,0.0001873308,0.00049768,0.0003361082,0.0002754314,0.0009542824,0.0001197391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000673677,"about_ca_system_score_gemma":0.001029583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005102718,"about_ca_topic_score_gemma":0.001589739,"domain_scores_codex":[0.9992008,0.0005044064,0.0000397547,0.0000805898,0.00009025061,0.00008421128],"domain_scores_gemma":[0.9990669,0.0002648464,0.0002677698,0.00006582252,0.00003605645,0.0002986522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8860831,0.005385393,0.0627656,0.0002205413,0.001847522,0.0000707701,0.00007896919,0.0015273,0.006797959,0.0001008801,0.0006669978,0.03445495],"study_design_scores_gemma":[0.3454576,0.2968876,0.3373904,0.000102025,0.002930844,0.0005140143,0.0001333452,0.007446837,0.006579668,0.0006851665,0.001817605,0.00005484236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991056,0.0004472526,0.00006421958,0.00006151824,0.00001099168,0.00007455223,0.00006496599,0.000003788798,0.0001671209],"genre_scores_gemma":[0.9990329,0.0001735069,0.0001464903,0.00008407245,0.0000309516,0.0001197619,0.000215376,0.000001476279,0.0001956043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002016183,"threshold_uncertainty_score":0.01066273,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05395772915114432,"score_gpt":0.3880574014701381,"score_spread":0.3340996723189937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}